Khurana, Surender <br/><br/>
H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans.  [electronic resource] 

 -  Journal of virology  Nov 2011 
 - 10945-54 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1098-5514 
<br/><br/><label>Standard No.: </label>10.1128/JVI.05406-11  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Neutralizing--blood<br/>Antibodies, Viral--blood<br/>Cell Line<br/>Cross Reactions<br/>Epitope Mapping<br/>Hemagglutinin Glycoproteins, Influenza Virus--immunology<br/>Humans<br/>Influenza A Virus, H5N1 Subtype--immunology<br/>Influenza Vaccines--immunology<br/>Neuraminidase--immunology<br/>Neutralization Tests<br/>Protein Binding<br/>Spodoptera<br/>Vaccines, Virosome--immunology<br/>Viral Proteins--immunology